Targeting MRPL37 disrupts the pro-tumorigenic mitochondrial cascade in bladder cancer: from LRPPRC deficiency to ROS/AKT axis inhibition.
Leng X, Lu W, Zhou R, Wang C, Wang Z, Peng H, Guo Y, Huang B, Pan D, Wang D, Su Z, Liu X, Liang X, Guo T, Liang W, Chen W, Huang Z, Chen Z, Zhang Y, Wang F
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.